209 related articles for article (PubMed ID: 16357447)
21. Particular association of clinical and genetic features with autoimmunity to citrullinated α-enolase in rheumatoid arthritis.
Montes A; Dieguez-Gonzalez R; Perez-Pampin E; Calaza M; Mera-Varela A; Gomez-Reino JJ; Gonzalez A
Arthritis Rheum; 2011 Mar; 63(3):654-61. PubMed ID: 21360494
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to citrullinated peptides are not associated with the rate of joint destruction in patients with a well-established diagnosis of rheumatoid arthritis.
Nieto-Colonia AM; Santos WS; Keusseyan SP; Caldana W; Fernandes AR; Andrade LE
Braz J Med Biol Res; 2008 Mar; 41(3):188-92. PubMed ID: 18235966
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
[TBL] [Abstract][Full Text] [Related]
25. Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking.
Roos K; Martinsson K; Ziegelasch M; Sommarin Y; Svärd A; Skogh T; Kastbom A
Arthritis Res Ther; 2016 May; 18(1):119. PubMed ID: 27215344
[TBL] [Abstract][Full Text] [Related]
26. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
[TBL] [Abstract][Full Text] [Related]
27. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
28. The differential expressions of 78-kDa glucose-regulated protein of infiltrating plasma cells in peripheral joints with the histopathological variants of rheumatoid synovitis.
Dong W; Li X; Feng Y; Fan C; Chen Z; Zhu P
Arthritis Res Ther; 2009 Jan; 11(1):R4. PubMed ID: 19128512
[TBL] [Abstract][Full Text] [Related]
29. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.
Farid SSh; Azizi G; Mirshafiey A
Int J Rheum Dis; 2013 Aug; 16(4):379-86. PubMed ID: 23992255
[TBL] [Abstract][Full Text] [Related]
30. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA
J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
32. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue.
Vossenaar ER; Smeets TJ; Kraan MC; Raats JM; van Venrooij WJ; Tak PP
Arthritis Rheum; 2004 Nov; 50(11):3485-94. PubMed ID: 15529392
[TBL] [Abstract][Full Text] [Related]
33. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
van Venrooij WJ; van Beers JJ; Pruijn GJ
Ann N Y Acad Sci; 2008 Nov; 1143():268-85. PubMed ID: 19076355
[TBL] [Abstract][Full Text] [Related]
34. The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors?
López-Longo FJ; Sánchez-Ramón S; Carreño L
Drug News Perspect; 2009 Nov; 22(9):543-8. PubMed ID: 20072731
[TBL] [Abstract][Full Text] [Related]
35. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.
Kinloch A; Lundberg K; Wait R; Wegner N; Lim NH; Zendman AJ; Saxne T; Malmström V; Venables PJ
Arthritis Rheum; 2008 Aug; 58(8):2287-95. PubMed ID: 18668562
[TBL] [Abstract][Full Text] [Related]
36. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR
Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
[TBL] [Abstract][Full Text] [Related]
37. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
Zhu T; Feng L
Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies.
Faragó B; Talián GC; Maász A; Magyari L; Horvatovich K; Kovács B; Cserép V; Kisfali P; Kiss CG; Czirják L; Melegh B
Clin Exp Rheumatol; 2007; 25(4):523-8. PubMed ID: 17888206
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
40. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
